TFS CAPITAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2017$1,233,000
+431.5%
30,385
+373.7%
0.40%
+614.3%
Q3 2016$232,000
-77.4%
6,415
-81.9%
0.06%
-70.4%
Q2 2016$1,028,000
-18.5%
35,457
-9.2%
0.19%
+54.9%
Q3 2015$1,262,000
+22.2%
39,048
+56.3%
0.12%
+20.8%
Q2 2015$1,033,000
-67.8%
24,987
-72.5%
0.10%
-60.1%
Q2 2014$3,210,000
+37.2%
90,988
+26.8%
0.25%
+63.2%
Q1 2014$2,339,000
+723.6%
71,780
+908.4%
0.16%
+1092.3%
Q3 2013$284,000
-13.9%
7,118
-10.8%
0.01%
-7.1%
Q2 2013$330,0007,9770.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders